Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.72 |
| ▸ | CA1 | P00915 | 1/20 | 0.71 |
| ▸ | CES2 | O00748 | 4/20 | 0.67 |
| ▸ | CES1 | P23141 | 4/20 | 0.67 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nonanoate SCHEMBL9296766 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Undecanoate SCHEMBL5857955 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Stearic Acid SCHEMBL935 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Heptanoate SCHEMBL267659 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Pentadecanoic Acid SCHEMBL18429968 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Myristic Acid SCHEMBL8003084 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Arachidic Acid SCHEMBL11867584 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Stearic Acid SCHEMBL5694020 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Stearic Acid SCHEMBL4655901 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 | |
| Palmitic Acid SCHEMBL103017 | 1.00 | FABP3 (0.72) | FABP3CA1CES2CES1FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240335364-A1 | COMPOSITIONS OF DICAFFEOYLQUINIC ACIDS WITH TOCOPHEROL | SYMRISE AG (DE) | 2024-10-10 | — | — | US | disclosed |
| US-20240139235-A1 | IRON(III) FORMULATIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | PHARMANUTRA S.P.A. (IT) | 2024-05-02 | — | — | US | disclosed |
| EP-4304607-A1 | IRON(III) FORMULATIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | Pharmanutra S.p.A. (IT) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022190072-A1 | IRON(III) FORMULATIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION | PHARMANUTRA S.P.A. (IT) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022119230-A1 | ANTI-ALLERGIC COMPOSITION USING EXTRACT FROM PERSICARIA LONGISETA | 재단법인 경기도경제과학진흥원 | 2022-06-09 | — | — | WO | disclosed |
| WO-2022119229-A1 | COMPOSITION EMPLOYING SCIRPUS KARUIZAWENSIS EXTRACT FOR ALLEVIATION OF ATOPIC DERMATITIS | 재단법인 경기도경제과학진흥원 | 2022-06-09 | — | — | WO | disclosed |
| WO-2022045540-A1 | COMPOSITION FOR IMPROVING MUSCLE STRENGTH, ALLEVIATING MUSCLE ATROPHY, OR ALLEVIATING AGING-INDUCED SARCOPENIA BY USING ISHIGE OKAMURAE EXTRACT OR COMPOUND ISOLATED THEREFROM | 제주대학교 산학협력단 | 2022-03-03 | — | — | WO | disclosed |
| EP-3711763-A1 | CONTROLLED RELEASE FORMULATION | Nippon Shinyaku Co., Ltd. (JP) | 2020-09-23 | — | — | EP | disclosed |
| EP-3697391-A1 | MINI-TABLETS | DFE Pharma GmbH & Co. KG (DE) | 2020-08-26 | — | — | EP | disclosed |
| WO-2020060426-A1 | AN ORAL PREPARATION CONTAINING SODIUM BUTYRATE | NERR PHARMA SPOŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ (PL) | 2020-03-26 | — | — | WO | disclosed |
| WO-1995022325-A1 | COMPOSITIONS CONTAINING MICRONIZED NEBIVOLOL | JANSSEN PHARMACEUTICA N.V. (BE) | 1995-08-24 | — | — | WO | disclosed |
| US-5391359-A | Water dispersible thickeners comprising hydrophilic polymers coated with particulate fatty acids or the salts thereof | PHILLIPS PETROLEUM COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| US-5275825-A | Coated granules of pharmaceutical composition with non-coated non-swelling polymer | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-01-04 | — | — | US | disclosed |
| WO-1993019741-A1 | A pharmaceutical formulation | BENZON PHARMA A/S (DK) | 1993-10-14 | — | — | WO | disclosed |
| EP-0355247-B1 | COMPRESSED-MOLDED PREPARATIONS | SS PHARMACEUTICAL CO., LTD. (JP) | 1993-08-11 | — | — | EP | disclosed |
| US-5186943-A | Non-swelling polymer coating, controlled drug release | SS PHARMACEUTICAL CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| CN-1068104-A | The Catalyst And Method of preparation vinyl-acetic ester | HOECHST AG (DE) | 1993-01-20 | — | — | CN | disclosed |
| CN-1066184-A | The tablet formulation of optimizing | MERCK & CO INC (US) | 1992-11-18 | — | — | CN | disclosed |
| EP-0355247-A2 | Compressed-molded preparations | SS PHARMACEUTICAL CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
| US-3933762-A | Hot melt adhesives from lactam copolyamides | TORAY INDUSTRIES, INC. (JA) | 1976-01-20 | — | — | US | disclosed |